menu
    • menu

    Company profile for Alopexx Oncology

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Alopexx Enterprises works with scientists and entrepreneurs to build successful new companies. We invest in novel health care technologies at all stages of development and can serve as a lead investor or collaborate with a group of investors to advance important science. We also have the capabilities to provide management and development expertise where needed. To date, our initial investments have ranged from $1-20M. Th...
    Alopexx Enterprises works with scientists and entrepreneurs to build successful new companies. We invest in novel health care technologies at all stages of development and can serve as a lead investor or collaborate with a group of investors to advance important science. We also have the capabilities to provide management and development expertise where needed. To date, our initial investments have ranged from $1-20M. The Alopexx team consists of experts who have deep industry knowledge and technical expertise in all areas of drug development including, pharmacology, CMC, toxicology, medical and clinical operations.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Alopexx OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Main Street, Suite 110. Concord, MA 01742
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.alopexx.com/home-2/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alopexx Collaborates With Bharat Biotech On Vaccine AV0328
    Alopexx Collaborates With Bharat Biotech On Vaccine AV0328

    10 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/10/2943748/0/en/Alopexx-Announces-Collaboration-with-Bharat-Biotech-for-the-Development-and-Commercialization-of-Broad-Spectrum-Anti-Microbial-Vaccine-AV0328.html

    GLOBENEWSWIRE
    10 Sep 2024
    Share Share
    Alopexx Announces Investment from Biotech Consortia, Inc.
    Alopexx Announces Investment from Biotech Consortia, Inc.

    06 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/06/2942180/0/en/Alopexx-Announces-Investment-from-Biotech-Consortia-Inc.html

    GLOBENEWSWIRE
    06 Sep 2024
    Share Share
    Alopexx to Present Data on F598, a Novel, Broad-Spectrum Immunotherapeutic
    Alopexx to Present Data on F598, a Novel, Broad-Spectrum Immunotherapeutic

    12 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alopexx-to-present-data-on-f598-a-novel-broad-spectrum-immunotherapeutic-at-idweek-2023-301954936.html

    PR NEWSWIRE
    12 Oct 2023
    Share Share
    Alopexx Announces Presentation at IDWeek 2023
    Alopexx Announces Presentation at IDWeek 2023

    11 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alopexx-announces-presentation-at-idweek-2023-301952906.html

    PR NEWSWIRE
    11 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search